(Q37060108)

18 August 2017

1 reference

title

A review of complementary and alternative approaches to immunomodulation (English)

1 reference

18 August 2017

2

Gerard E Mullin

1 reference

18 August 2017

John O Clarke

1

1 reference

18 August 2017

1 February 2008

1 reference

Nutrition in Clinical Practice

18 August 2017

1 reference

18 August 2017

23

1 reference

18 August 2017

1

1 reference

18 August 2017

49-62

1 reference

Diet and cancer: facts and controversies

18 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Green tea polyphenol extract attenuates colon injury induced by experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Antioxidants as novel therapy in a murine model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin attenuates DNB-induced murine colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effects of Boswellia serrata in mouse models of chemically induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resveratrol: a review of preclinical studies for human cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Potent inhibitory action of red wine polyphenols on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effects of resveratrol on human immune cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of resveratrol on herpes simplex virus vaginal infection in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Regulation of inflammation and redox signaling by dietary polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Beneficial effects of green tea--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Green tea and risk of breast cancer in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Protective effect of green tea against prostate cancer: A case‐control study in southeast China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of life styles on the risk of subsite-specific gastric cancer in those with and without family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Protective effect of green tea on the risks of chronic gastritis and stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

The protective effect of habitual tea consumption on hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Flavonoid Intake and Long-term Risk of Coronary Heart Disease and Cancer in the Seven Countries Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Coffee and tea intake and the risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Does tea affect cardiovascular disease? A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Tea as a functional food for oral health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Cutaneous photoprotection from ultraviolet injury by green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Skin photoprotection by green tea: antioxidant and immunomodulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Relationship among habitual tea consumption, percent body fat, and body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effects of green tea on weight maintenance after body-weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Tea enhances insulin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Flavonoids: antioxidants or signalling molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Multiple biological activities of curcumin: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

"Spicing up" of the immune system by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin ameliorates ethanol and nonethanol experimental pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Antioxidant activity of curcumin and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Chemopreventive and therapeutic effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin therapy in inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Boswellic acids in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Boswellic acids: biological actions and molecular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effects of gum resin of Boswellia serrata in patients with chronic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Fish oil: what the prescriber needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Safety considerations with omega-3 fatty acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Influence of fish consumption on the distribution of serum cholesterol in lipoprotein fractions: comparative study among fish-consuming and non-fish-consuming populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2(I) promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Vitamin d and its role in cancer and immunity: a prescription for sunlight

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Gut flora in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Probiotics and prebiotics in chronic inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

The role of probiotics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

A pilot trial of Saccharomyces boulardii in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Treatment of ulcerative colitis using fecal bacteriotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Review article: complementary and alternative therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650802300149

10.1177/011542650802300149

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18203964